Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
APC mutation
Cancer:
Colorectal Cancer
Drug:
Avastin (bevacizumab)
(
VEGF-A inhibitor
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
Source:
Oncol Res
Title:
Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer
Published date:
09/25/2023
Excerpt:
APC mutation status was a significantly enriched factor in responders to bevacizumab treatment.
DOI:
10.32604/or.2023.030374
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login